Dnmt3a-mediated hypermethylation of FoxO3 promotes redox imbalance during osteoclastogenesis
Authors:
Open Access
- 19 March 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (12)
Abstract
Redox imbalance contributes to aberrant osteoclastogenesis and osteoporotic bone loss. In this study, we observed lower Forkhead box protein O3 (FoxO3), a transcription factor associated with cellular oxidative stress, enhanced osteoclastogenesis in osteoporosis (OP). Single-cell RNA sequencing (scRNA-seq) analysis on the human femoral head indicated that FoxO3 is widely expressed in macrophages. Furthermore, Lysm-Cre;FoxO3 f/f OVX mice showed increased reactive oxygen species (ROS), enhanced osteoclastogenesis, and more bone loss than normal OVX mice. Mechanistically, we identified FoxO3 promoter methylation as a crucial factor contributing to decreased FoxO3, thereby influencing osteoclastogenesis and OC function. Intriguingly, we observed that Dnmt3a, highly expressed during osteoclastogenesis, played a pivotal role in regulating the methylation of the FoxO3 promoter. Knockdown of Dnmt3a promoted FoxO3 expression, inhibiting osteoclastogenesis and mitigating OP. Interestingly, we observed that Dnmt3a alleviated osteoclastogenesis by suppressing ROS via upregulating FoxO3 rather than inducing the dissociation of RANK and TRAF6. Collectively, this study elucidates the role and mechanism of FoxO3 in osteoclastogenesis and OP, providing a epigenetic target for the treatment of OP.Keywords
Funding Information
- Natural Science Foundation for Young Scientists of Shanxi Province (82072425 82072498 82272567)
This publication has 83 references indexed in Scilit:
- Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevityAgeing Research Reviews, 2022
- The DNA methylation inhibitor RG108 protects against noise-induced hearing lossCell Biology and Toxicology, 2021
- Patisiran: First Global ApprovalDrugs, 2018
- Overexpression of DNMT1 leads to hypermethylation of H19 promoter and inhibition of Erk signaling pathway in disuse osteoporosisBone, 2018
- SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROSJournal of Bone and Mineral Research, 2016
- Methylation of Bone SOST, Its mRNA, and Serum Sclerostin Levels Correlate Strongly With Fracture Risk in Postmenopausal WomenJournal of Bone and Mineral Research, 2014
- FoxO4 inhibits atherosclerosis through its function in bone marrow derived cellsAtherosclerosis, 2011
- Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineageBone, 2011
- Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linkingJournal of Bone and Mineral Research, 2011
- Phosphatidylinositol 3‐kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survivalJournal of Cellular Biochemistry, 2003